Clinical trial
A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis
NCT04927390 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis
- Lead sponsor
- University College, London
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 8, 2021
- Completion date
- April 30, 2024
- Enrollment
- 120 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
limited cutaneous systemic sclerosis, systemic sclerosis